Genomeditech (Shanghai) Co., Ltd., established in 2011, is a high-tech enterprise specializing in cutting-edge biotechnology research and development.
Genomeditech established the cell line brand DDXCELL in 2020 and has since secured commercial usage rights for HEK293, Jurkat E6.1, and CHO-K1 cell lines, allowing the company to modify, develop, and distribute these cell lines. With clear traceability documentation, Genomeditech helps users mitigate intellectual property risks throughout the development process.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Shanghai, Pudong New Area
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://en.genomeditech.com/
- Keywords
- Southborough.
- HQ
- shanghai, Pudong New Area
Genomeditech (Shanghai) Co., Ltd Questions
Genomeditech (Shanghai) Co., Ltd's website is https://en.genomeditech.com/
Genomeditech (Shanghai) Co., Ltd's LinkedIn profile is https://cn.linkedin.com/company/genomeditech
Genomeditech (Shanghai) Co., Ltd has
11 employees.
View email and phone details for 11
employees at Genomeditech (Shanghai) Co., Ltd.
Genomeditech (Shanghai) Co., Ltd's industry is
Biotechnology Research
Genomeditech (Shanghai) Co., Ltd's top competitors are
Novartis,
Bioivt,
Bioduro,
Astrazeneca,
Intra-Cellular Therapies,
Veristat,
Gsk,
Igenetech Bioscience,
Novo Nordisk,
Roche.
Genomeditech (Shanghai) Co., Ltd's categories are Biotechnology Research
Genomeditech (Shanghai) Co., Ltd's founding year is 2011
